Authors: Weibert, RT Yeager, BF Wittkowsky, AK Bussey, HI Wilson, DB Godwin, JE Adler, DS Black, EA McGee, DL Vlasses, PH

Citation: Rt. Weibert et al., A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation, ANN PHARMAC, 34(9), 2000, pp. 981-988

Authors: Bennett, CL Stinson, TJ Laver, JH Bishop, MR Godwin, JE Tallman, MS

Citation: Cl. Bennett et al., Cost analyses of adjunct colony stimulating factors for acute leukemia: Can they improve clinical decision making, LEUK LYMPH, 37(1-2), 2000, pp. 65-70

Authors: Chauncey, TR Rankin, C Anderson, JE Chen, IM Kopecky, KJ Godwin, JE Kalaycio, ME Moore, DF Shurafa, MS Petersdorf, SH Kraut, EH Leith, CP Head, DR Luthardt, FW Willman, CL Appelbaum, FR

Citation: Tr. Chauncey et al., A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617, LEUK RES, 24(7), 2000, pp. 567-574

Authors: Shin, DD Godwin, JE

Citation: Dd. Shin et Je. Godwin, Takayasu's arteritis associated with factor V Leiden, AM J HEMAT, 60(3), 1999, pp. 237-238